Sartorius reports dynamic growth figures for 2015

Sartorius has announced its financial results for 2015, during which it experienced strong growth in terms of revenue and earnings.

Its consolidated sales revenue figure for the year rose by 16 percent year over year to 1.11 billion euros (863.98 million pounds), while its underlying earnings were up by 40.9 percent to 263.2 million euros.

The dynamic development of its bioprocess solutions division was cited as a key driver of this improvement, as well as the strong growth seen in the lab products and services division.

It was also able to expand its market share within the biopharmaceutical industry and progressed with its multi-year investment programme, which will help to lay the foundation for future sustainable growth.

In 2016, Sartorius expects its sales will grow by between ten and 14 percent on a constant currency basis.

Dr Joachim Kreuzburg, chief executive officer of Sartorius, said: "We achieved or exceeded our financial targets for 2015. The bioprocess solutions division proved to be the growth engine again, recording double-digit gains for the fifth year in succession."